NEW YORK–(BUSINESS WIRE)–Rowley Law PLLC is investigating potential securities law violations by Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) and its board of directors concerning the proposed acquisition of the company by members of Cellular Biomedicine Group’s senior management and other investors. Stockholders will receive $19.75 in cash for each share of Cellular Biomedicine Group stock that they hold. The transaction is expected to close in the fourth quarter of 2020.
If you are a stockholder of Cellular Biomedicine Group, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/cbmg/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Shane Rowley, Esq.
Rowley Law PLLC
50 Main Street Suite 1000
White Plains, NY 10606
914-400-1920 or 844-400-4643 (toll-free)
Powered by WPeMatico